共 83 条
[1]
McCrindle BW(2012)Guidelines for lipid screening in children and adolescents: bringing evidence to the debate Pediatrics 130 353-356
[2]
Kwiterovich PO(2011)Familial hypercholesterolemia: screening, diagnosis and management of pediatric and adult patients: clinical guidance from the National Lipid Association Expert Panel on Familial Hypercholesterolemia J Clin Lipidol 5 133-140
[3]
McBride PE(2015)European atherosclerosis society consensus panel. Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment Eur Heart J 36 2425-2437
[4]
Daniels SR(2014)Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation Int J Cardiol 171 309-325
[5]
Kavey RE(2016)Lipid Association of India Expert Consensus Statement on management of dyslipidemia in Indians 2016: part 1 J Assoc Physicians India 64 7-52
[6]
Goldberg AC(2004)Genetic causes of monogenic heterozygous familial hypercholesterolaemia: a HuGE prevalence review Am J Epidemiol 160 407-420
[7]
Hopkins PN(2016)Pooling and expanding registries of familial hypercholesterolaemia to assess gaps in care and improve disease management and outcomes: rationale and design of the global EAS Familial Hypercholesterolaemia Studies Collaboration Atheroscler Suppl 22 1-32
[8]
Toth PP(2015)Prevalence and pattern of dyslipidemia in 2500 adolescents in suburban india J Am Coll Cardiol 65 A1486-3
[9]
Wiegman A(2017)Can we afford not to screen for FH? Eur Heart J 0 1-400
[10]
Gidding SS(2014)Cascade screening based on genetic testing is cost-effective: evidence for the implementation of models of care for familial hypercholesterolemia J Clin Lipidol 8 390-507